Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Bioventus (BVS) Asset Utilization Ratio (2021 - 2026)

Bioventus posted quarterly Asset Utilization Ratio of 0.86 for Q1 2026, up 8.0% year-on-year from 0.8 in Q1 2025, and up 5.33% on a QoQ basis from 0.82 in Q4 2025.

Bioventus (BVS) has 6 years of Asset Utilization Ratio data on file, last reported at 0.86 in Q1 2026.

  • For the quarter ending Q1 2026, Asset Utilization Ratio rose 8.0% year-over-year to 0.86; the trailing twelve-month figure through Mar 2026 stood at 0.86 (up 8.0% YoY), and the FY2025 full-year result was 0.8, up 8.03% from the prior year.
  • Asset Utilization Ratio for Q1 2026 stood at 0.86, up from 0.82 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.86 in Q1 2026 and bottomed at 0.37 in Q4 2022.
  • The 5-year median for Asset Utilization Ratio is 0.65 (2024), against an average of 0.63.
  • The widest annual swing landed in 2022, when Asset Utilization Ratio tumbled 35.36%; it then jumped 70.89% in 2023.
  • A 5-year view of Asset Utilization Ratio shows it stood at 0.37 in 2022, then jumped by 70.89% to 0.63 in 2023, then rose by 21.2% to 0.77 in 2024, then climbed by 7.13% to 0.82 in 2025, then climbed by 5.33% to 0.86 in 2026.
  • The last three Asset Utilization Ratio figures came in at 0.86 (Q1 2026), 0.82 (Q4 2025), and 0.8 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 0.46
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 0.54
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 0.39
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 0.47
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 0.47
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 0.65
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 0.74
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 0.57
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 0.56
10 Bioventus 535.01 Mn 544.52 Mn 90.77 Mn 0.86

Historic Data

Download Data 🔒
DateValue
Mar 28, 2026 0.86
Dec 31, 2025 0.82
Sep 27, 2025 0.80
Jun 28, 2025 0.81
Mar 29, 2025 0.80
Dec 31, 2024 0.77
Sep 28, 2024 0.71
Jun 29, 2024 0.68
Mar 30, 2024 0.65
Dec 31, 2023 0.63
Sep 30, 2023 0.61
Jul 1, 2023 0.59
Apr 1, 2023 0.45
Dec 31, 2022 0.37
Oct 1, 2022 0.40
Jul 2, 2022 0.41
Apr 2, 2022 0.38
Dec 31, 2021 0.46
Oct 2, 2021 0.61
Jul 3, 2021 0.58
Apr 3, 2021 0.57